News

Information Nov 4, 2026
Elix to Host a Luncheon Seminar and Exhibit at the 43rd Medicinal Chemistry Symposium
Information Oct 13, 2026
Elix will Participate in the Chem-Bio Informatics Society (CBI) Annual Meeting 2026 with Luncheon Seminar, Sponsored Session, Oral Presentation, Booth Exhibition, and Sponsor the Elix Café
Information Sep 28, 2026
Elix will exhibit and participate in partnering at BioJapan 2026
Information Sep 10, 2026
Article on Joint Research Agreement Between Elix and Axcelead DDP on Targeted Protein Degraders Featured in AnswersNews
Information Sep 10, 2026
Article on Joint Research Agreement Between Elix and Axcelead DDP on Targeted Protein Degraders Featured in Daily Yakugyo
News Release Sep 9, 2026
Elix and Axcelead DDP Enter into Collaborative Research Agreement to Advance Targeted Protein Degrader Discovery: Combining AI Drug Discovery Technologies with Drug Discovery Expertise to Advance Solutions for Challenging Targets
Information Aug 24, 2026
Article on Joint Research with University of Vienna Using AI and NMR Featured in Nikkei Biotech ONLINE
Information Aug 3, 2026
Articles on the Joint Research Agreement Between Elix and the University of Vienna for AI-Driven Drug Discovery Featured in International Media
News Release Jul 29, 2026
Elix, an AI Drug Discovery Company and University of Vienna Enter into Joint Research Agreement to Advance Drug Discovery Using AI Technology
Information Jul 13, 2026
Elix will exhibit at the AI-Driven Drug Discovery Forum on July 14

Contact Us

Thank you for your interest in Elix. If you have any inquiries about our AI drug discovery platform or conducting joint research, or if you would like to conduct an interview with us, please click the Contact button on the right to get in touch with us.
We will respond as soon as possible.